Is Halozyme Therapeutics (HALO) Pricing Reflect Long Term Prospects After Recent Share Pullback [Yahoo! Finance]
Halozyme Therapeutics, Inc. (HALO)
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
halozyme.com/investors/default.aspx
Company Research
Source: Yahoo! Finance
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are wondering whether Halozyme Therapeutics at around US$69.40 is still attractively priced or starting to look expensive, you are in the right place. The share price closed at US$69.40, with returns of a 1.4% decline over 7 days, a 3.2% decline over 30 days, a 1.3% decline year to date, but 19.4% over 1 year, 59.9% over 3 years and 65.8% over 5 years, which can shape how the market is currently weighing its risks and opportunities. Recent attention on Halozyme has been influenced by ongoing interest in its drug delivery platforms and partnership pipeline, which can affect how investors think about its long term prospects. These themes often feed into sentiment around contract wins, regulatory updates or new collaborations, and all of these can move the share price even without fresh financial results. On our valuation checklist,
Show less
Read more
Impact Snapshot
Event Time:
HALO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HALO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HALO alerts
High impacting Halozyme Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HALO
News
- Halozyme Therapeutics (HALO) Valuation Check As Recent Share Pullback Follows Strong Multi Year Returns [Yahoo! Finance]Yahoo! Finance
- Halozyme Therapeutics, Inc. (HALO) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- Is Halozyme Therapeutics (HALO) a Buy Post Earnings? [Yahoo! Finance]Yahoo! Finance
- Halozyme Therapeutics, Inc. (HALO): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Halozyme Therapeutics (HALO) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "buy (b-)" to "hold (c)".MarketBeat
HALO
Earnings
- 2/17/26 - Miss
HALO
Sec Filings
- 3/4/26 - Form 4
- 2/24/26 - Form 4
- 2/24/26 - Form 4
- HALO's page on the SEC website